Molecular surface descriptors to predict antibody developability: sensitivity to parameters, structure models, and conformational sampling
In silico assessment of antibody developability during early lead candidate selection and optimization is of paramount importance, offering a rapid and material-free screening approach. However, the predictive power and reproducibility of such methods depend heavily on the selection of molecular des...
Saved in:
Main Authors: | Eliott Park, Saeed Izadi |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | mAbs |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2024.2362788 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Residue-resolved insights into the stabilization of therapeutic proteins by excipients: A case study of two monoclonal antibodies with arginine and glutamate
by: Tobias M. Prass, et al.
Published: (2024-12-01) -
Assessment and incorporation of in vitro correlates to pharmacokinetic outcomes in antibody developability workflows
by: Tushar Jain, et al.
Published: (2024-12-01) -
Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG1 antibodies
by: Wen-Ting K. Tsai, et al.
Published: (2024-12-01) -
Engineering hydrophobicity and manufacturability for optimized biparatopic antibody–drug conjugates targeting c-MET
by: Andreas Evers, et al.
Published: (2024-12-01) -
Exploring molecular determinants and pharmacokinetic properties of IgG1-scFv bispecific antibodies
by: Kristina M.J. Aertker, et al.
Published: (2024-12-01)